Overview

Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary Care

Status:
Completed

Trial end date:
2007-05-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to determine if the administration of small doses of Acarbose can prevent or delay the appearance of Type 2 Diabetes Mellitus in a population of subjects with prediabetes.

Phase:

Phase 3

Details

Lead Sponsor:

Bayer

Treatments:

Acarbose